Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Cresco Labs stock

CL.CN
CA22587M1068
A2PAHM

Price

1.67
Today +/-
+0.02
Today %
+1.06 %
P

Cresco Labs stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Cresco Labs stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Cresco Labs stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Cresco Labs stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Cresco Labs's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Cresco Labs Stock Price History

DateCresco Labs Price
9/30/20241.67 undefined
9/27/20241.65 undefined
9/26/20241.68 undefined
9/25/20241.69 undefined
9/24/20241.71 undefined
9/23/20241.67 undefined
9/20/20241.60 undefined
9/19/20241.65 undefined
9/18/20241.64 undefined
9/17/20241.65 undefined
9/16/20241.70 undefined
9/13/20241.67 undefined
9/12/20241.66 undefined
9/11/20241.66 undefined
9/10/20241.68 undefined
9/9/20241.75 undefined
9/6/20241.58 undefined
9/5/20241.64 undefined
9/4/20241.68 undefined
9/3/20241.66 undefined

Cresco Labs Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Cresco Labs, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cresco Labs from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cresco Labs’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cresco Labs. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cresco Labs’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cresco Labs’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cresco Labs’s growth potential.

Cresco Labs Revenue, EBIT and net profit per share

DateCresco Labs RevenueCresco Labs EBITCresco Labs Net Income
2026e879 M undefined202.6 M undefined3.39 M undefined
2025e801.75 M undefined147.5 M undefined-3.39 M undefined
2024e765.59 M undefined123.77 M undefined-52.93 M undefined
2023770.89 M undefined63.19 M undefined-175.52 M undefined
2022842.68 M undefined56.36 M undefined-212.05 M undefined
2021821.68 M undefined88.54 M undefined-319.6 M undefined
2020476.25 M undefined-22.25 M undefined-102.16 M undefined
2019128.53 M undefined-52.71 M undefined-43.2 M undefined
201843.25 M undefined-44.13 M undefined-1.92 M undefined
20170 undefined-41,275 undefined-79,310 undefined
20160 undefined-42,299 undefined-106,628 undefined
20140 undefined-46,397 undefined-74,317 undefined

Cresco Labs Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2014201620172018201920202021202220232024e2025e2026e
00043128476821842770765801879
----197.67271.8872.482.56-8.55-0.654.719.74
----27.9135.1643.2849.4548.3447.01---
000-1245206406407362000
000-44-52-22885663123147202
----102.33-40.63-4.6210.726.658.1816.0818.3522.98
000-1-43-102-319-212-175-52-33
----4,200.00137.21212.75-33.54-17.45-70.29-94.23-200.00
28.2728.2728.2759.34118.32210.47262.33298.16323.82000
------------
Details

Keystats

Revenue and Growth

The Cresco Labs Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cresco Labs is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                       
000000001.20.40.10.40.20.100000000131.349.1136.34223.54119.34103.43
00000000000000000000003.6616.4629.9443.3856.4951.07
00000000000000000000007.730.642.441.310.451.42
000000000000000000000024.5281.3567.18136.64134.61107.79
00000000.60000000000000.07025.511.7913.5616.8815.1614.38
00000000.61.20.40.10.40.20.10000000.070192.7159.34249.47421.75326.05278.09
0.80.80.10.10.10.10.10.10.10.60.50.642.40.40.20.20.100.120039.72202.54300.6457.11507.99486.19
00000000000000000000000.431.284.365.911.230.73
00000000000000000000007.2818.6321.220.510.820.83
000000000000000000000025.4694.21195.54437.64407.59296.97
000000000000000000000051.15137.72450.57446.77330.56279.7
0.40.20.10.30.20.30.30.31.43.94.45.800000000001.362.8510.8410.779.4615.97
000000000000.0100000000000.130.460.981.361.261.08
00000000000.010.0100000000000.320.621.231.781.581.36
                                                       
000000000.010.010.010.010.010.010.010.010.010.010.010.010.010.010.160.280.81.61.71.69
000.100.1000.20.51.61.732.53.13.3003.22.522.732.692.6911.5925.8600082.93
-1.2-1.4-2.8-3.2-3.6-3.3-3.4-4.4-5.1-7-7.7-9.6-9.9-14.3-17.5-14.1-14.4-16.3-12.93-13.96-13.86-13.94-52.75-114.63-328.38-841.91-1,076.2-1,265.54
000000000000000000000000-0.65-0.25-1.39-1.15
0000000000000000000000000000
10.8-0.20-0.4-0.100.72.64.64.56.73.51.5-0.7-0.5-0.7-0.9-0.8-0.81-0.91-0.99121.03187.08473.24755.55627.04505.69
00.10.10.10.20.20.20.10.20.30.40.50.60.80.70.40.30.20.190.220.230.237.632.4623.2332.2828.0927.59
0000000000000000000000029.92130.4795.4465.1669.08
0.10.20.20.30.20.10.10000.100.30.10.30.40.70.80.720.710.750.4817.6475.7755.18119.95142.6882.34
0000000000000000000000.280025.9219.9318.819.81
0000000000000000000000012.0218.0420.7926.1211.42
0.10.30.30.40.40.30.30.10.20.30.50.50.90.910.8110.910.930.980.9925.23150.17252.85288.39280.87200.24
000.10.10.30.20.20.2000000.10.20000000083.41329.91584.02625.24661.52
00000000000000000000004.4623.2141.285.6775.1440.46
00000000000000000000005.4437.1433.3124.6514.7728.18
000.10.10.30.20.20.2000000.10.200000009.9143.76404.42694.33715.14730.16
0.10.30.40.50.70.50.50.30.20.30.50.50.911.20.8110.910.930.980.9935.13293.93657.26982.73996.01930.4
000000000000.0100000000000.160.481.131.741.621.44
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Cresco Labs provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cresco Labs's financial health and stability.

Assets

Cresco Labs's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cresco Labs must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cresco Labs after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cresco Labs's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017null201820192020202120222023
00-1000000-1-10-2-2-2000000003-65-92-296-215-179
0000000000000000000000021131385162
000000000000000000000001,0001,000-11,000-34,000-4,000-32,000
00000000000000000000000-1215-291315
00000000010012100000000-15559336173193
00000000000000000000000050395353
00000000000000000000000000734670
00000000000000000000000-9-25-7141858
000000000-2-1000000000000-29-96-89-97-86-57
000000000-20000000000000-81-107-64-163-36-44
00000000000000000000000-51-1124-664913
00000000000000000000000000000
00000000000000000000000-1-2174167-216
000000001101000000000002053914430
0000000011010000000000020248161235-86-26
00000000000000000000000-250-22-76-87-43
000000000000000000000000-20000
00000000000000000000000110-838785-104-12
0.02-0.16-0.37-0.23-0.05-0.07-0.09-0.25-0.98-2.55-1.18-1.02-0.53-0.35-0.17-0.220.030.01-0.040.09-0.020.030-39.86-121.32-97.11-82.57-67.390.68
00000000000000000000000000000

Cresco Labs stock margins

The Cresco Labs margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cresco Labs. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cresco Labs.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cresco Labs's sales revenue. A higher gross margin percentage indicates that the Cresco Labs retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cresco Labs's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cresco Labs's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cresco Labs's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cresco Labs. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cresco Labs's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cresco Labs Margin History

Cresco Labs Gross marginCresco Labs Profit marginCresco Labs EBIT marginCresco Labs Profit margin
2026e47.01 %23.05 %0.39 %
2025e47.01 %18.4 %-0.42 %
2024e47.01 %16.17 %-6.91 %
202347.01 %8.2 %-22.77 %
202248.3 %6.69 %-25.16 %
202149.45 %10.78 %-38.9 %
202043.4 %-4.67 %-21.45 %
201935.5 %-41.01 %-33.61 %
2018-28.08 %-102.02 %-4.43 %
201747.01 %0 %0 %
201647.01 %0 %0 %
201447.01 %0 %0 %

Cresco Labs Stock Sales Revenue, EBIT, Earnings per Share

The Cresco Labs earnings per share therefore indicates how much revenue Cresco Labs has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Cresco Labs earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cresco Labs's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cresco Labs’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cresco Labs's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cresco Labs Revenue, EBIT and net profit per share

DateCresco Labs Sales per ShareCresco Labs EBIT per shareCresco Labs Earnings per Share
2026e2.67 undefined0 undefined0.01 undefined
2025e2.43 undefined0 undefined-0.01 undefined
2024e2.32 undefined0 undefined-0.16 undefined
20232.38 undefined0.2 undefined-0.54 undefined
20222.83 undefined0.19 undefined-0.71 undefined
20213.13 undefined0.34 undefined-1.22 undefined
20202.26 undefined-0.11 undefined-0.49 undefined
20191.09 undefined-0.45 undefined-0.37 undefined
20180.73 undefined-0.74 undefined-0.03 undefined
20170 undefined-0 undefined-0 undefined
20160 undefined-0 undefined-0 undefined
20140 undefined-0 undefined-0 undefined

Cresco Labs business model

Cresco Labs Inc is an American cannabis and hemp company based in Chicago, Illinois. The company specializes in producing high-quality cannabis products and has a reputation for being innovative and reliable. Its diverse business model includes producing medical cannabis and recreational marijuana in various forms, as well as providing services such as consulting, training, marketing, and sales promotion. Cresco Labs has experienced impressive growth since its founding in 2013 and aims to expand its reach and product offerings. The company is committed to sustainability, social responsibility, and promoting education and access to medical cannabis. Cresco Labs is one of the most popular companies on Eulerpool.com.

Cresco Labs SWOT Analysis

Strengths

Cresco Labs Inc has a strong presence in the cannabis industry, with significant market share and a well-established brand.

The company has a diverse product portfolio that includes a wide range of cannabis strains and derivatives, catering to different consumer preferences.

Cresco Labs Inc boasts a robust distribution network, allowing them to reach customers in various markets effectively.

Weaknesses

As a cannabis company, Cresco Labs Inc faces legal and regulatory challenges in certain jurisdictions, which could limit its expansion opportunities.

The company heavily relies on the cannabis market, making it vulnerable to changes in regulations or consumer demand.

Cresco Labs Inc may face difficulties in building strong brand loyalty due to the highly competitive nature of the cannabis industry.

Opportunities

With the increasing legalization and acceptance of cannabis, Cresco Labs Inc can capitalize on new markets and expand its operations.

The company has the opportunity to further diversify its product offerings by exploring new cannabis derivatives or entering related industries, such as CBD products or infused beverages.

Growing consumer interest in natural and alternative remedies provides an opportunity for Cresco Labs Inc to promote the health benefits of cannabis products.

Threats

The cannabis industry faces stringent regulations and uncertainty, which poses a threat to Cresco Labs Inc's operations, particularly in regions where legalization is not widespread.

Intense competition within the cannabis market could put pressure on Cresco Labs Inc's pricing and profitability.

External factors such as economic downturns or changes in consumer preferences could impact the demand for cannabis products and affect the company's financial performance.

Cresco Labs Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Cresco Labs historical P/E ratio, EBIT multiple, and P/S ratio

Cresco Labs shares outstanding

The number of shares was Cresco Labs in 2023 — This indicates how many shares 323.82 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Cresco Labs earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cresco Labs's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cresco Labs’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cresco Labs's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Cresco Labs.

Cresco Labs latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.01 -0.16  (-1,140.31 %)2024 Q2
3/31/2024-0.02 -0.02  (6.1 %)2024 Q1
12/31/2023-0.02 0.01  (136.2 %)2023 Q4
9/30/2023-0.04 -0.34  (-767.35 %)2023 Q3
6/30/2023-0.04 -0.12  (-187.77 %)2023 Q2
3/31/2023-0.05 -0.09  (-74.42 %)2023 Q1
12/31/2022-0.03 -0.07  (-160.22 %)2022 Q4
9/30/2022-0.01 0.01  (179.37 %)2022 Q3
6/30/2022-0.01 0.07  (663.03 %)2022 Q2
3/31/2022-0.03  (-4,385.71 %)2022 Q1
1
2
3

Eulerpool ESG Scorecard© for the Cresco Labs stock

Eulerpool World ESG Rating (EESG©)

15/ 100

🌱 Environment

5

👫 Social

30

🏛️ Governance

9

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Cresco Labs shareholders

%
Name
Stocks
Change
Date
7.37565 % Nomura Securities Co., Ltd.24,298,18624,298,18612/31/2023
0.25191 % Bachtell (Charles Ian)829,88602/9/2024
0.22196 % Sampson (Robert Malcom)731,23102/9/2024
0.08850 % Sergi (Dominic)291,564291,56412/31/2023
0.08529 % Erkes (Jason Bennett)280,9691,2972/28/2024
0.06830 % BN & Partners Deutschland AG225,000-25,0002/29/2024
0.06593 % PenderFund Capital Management, Ltd.217,200110,0002/29/2024
0.06300 % Horizons ETFs Management (Canada) Inc.207,530-31,8602/29/2024
0.05987 % Olis (Dennis Martin)197,2362,9762/28/2024
0.05531 % Faircourt Asset Management Inc.182,20045,0002/29/2024
1
2
3
4
...
5

Cresco Labs Executives and Management Board

Mr. Charles Bachtell44
Cresco Labs Chief Executive Officer, Director (since 2018)
Compensation 999,850
Mr. Thomas Manning67
Cresco Labs Non-Executive Chairman of the Board (since 2019)
Compensation 800,050
Mr. Dennis Olis60
Cresco Labs Chief Financial Officer
Compensation 622,850
Mr. Gregory Butler43
Cresco Labs President
Mr. Ty Gent63
Cresco Labs Chief Operating Officer
1
2
3
4

Most common questions regarding Cresco Labs

What values and corporate philosophy does Cresco Labs represent?

Cresco Labs Inc represents values of innovation, quality, and community. With a strong corporate philosophy focused on providing safe and reliable cannabis products, Cresco Labs is committed to delivering excellence in every aspect of its business. The company prioritizes consumer satisfaction, ethical practices, and sustainability. Cresco Labs strives to be a leader in the cannabis industry by fostering strong partnerships, embracing diversity, and driving positive change. Through continuous research and development, Cresco Labs ensures that its offerings exceed market expectations, while always putting the well-being of its customers and the communities it serves at the forefront.

In which countries and regions is Cresco Labs primarily present?

Cresco Labs Inc is primarily present in the United States. With its headquarters in Chicago, Illinois, the company operates in various states across the country, including Illinois, Pennsylvania, Ohio, California, and more. As a leading multi-state cannabis operator, Cresco Labs Inc focuses on cultivation, manufacturing, and retail distribution of cannabis products. With its expansive presence in the U.S., the company strives to provide high-quality cannabis products to meet the growing demand in the legal cannabis market.

What significant milestones has the company Cresco Labs achieved?

Cresco Labs Inc has achieved several significant milestones. The company expanded its operations to 11 states in the U.S., becoming one of the largest multi-state cannabis operators. Additionally, it obtained key licenses to cultivate, process, and distribute cannabis products. Cresco Labs Inc also launched its own line of branded products, including edibles, vape pens, and oils. The company has been recognized for its excellence, winning multiple awards for its products and retail experiences. Moreover, Cresco Labs Inc's revenue and market presence continue to grow, solidifying its position as a leading player in the cannabis industry.

What is the history and background of the company Cresco Labs?

Cresco Labs Inc. is a prominent cannabis company with a rich history and background. Founded in 2013, Cresco Labs has positioned itself as a leading vertically integrated cannabis business in the United States. With operations in multiple states, including Illinois, Pennsylvania, and Ohio, the company focuses on all aspects of the cannabis industry, from cultivation and manufacturing to distribution and retail. Cresco Labs is committed to providing high-quality, safe, and consistent cannabis products to its customers. Over the years, the company has gained a strong reputation for its innovation, industry expertise, and commitment to regulatory compliance. With a mission to normalize and professionalize cannabis use, Cresco Labs continues to thrive and grow in the ever-evolving landscape of the cannabis industry.

Who are the main competitors of Cresco Labs in the market?

The main competitors of Cresco Labs Inc in the market are other leading cannabis companies, including Curaleaf Holdings Inc, Aphria Inc, Green Thumb Industries Inc, and Trulieve Cannabis Corp. These companies compete with Cresco Labs Inc in the cannabis industry by offering a range of cannabis products, including flower, edibles, concentrates, and topical solutions. Each competitor strives to establish its market dominance by implementing different strategies, providing innovative products, expanding their retail presence, and building strong brand awareness. Despite the competitive landscape, Cresco Labs Inc has managed to position itself as a key player in the cannabis market with its diverse product line, strategic acquisitions, and commitment to quality.

In which industries is Cresco Labs primarily active?

Cresco Labs Inc is primarily active in the cannabis industry.

What is the business model of Cresco Labs?

Cresco Labs Inc. operates under a vertically integrated business model within the cannabis industry. The company focuses on cultivating, manufacturing, and retailing premium cannabis products. By controlling the entire supply chain, Cresco Labs ensures quality and consistency for consumers. Their cultivation facilities employ advanced technologies to maximize yield and maintain product integrity. The company also operates dispensaries and partners with other brands to expand its reach. Through its strategic business model, Cresco Labs aims to provide high-quality cannabis products to both medical and recreational users, while also driving industry innovation and supporting local communities.

What is the P/E ratio of Cresco Labs 2024?

The Cresco Labs P/E ratio is -10.2.

What is the P/S ratio of Cresco Labs 2024?

The Cresco Labs P/S ratio is 0.71.

What is the AlleAktien quality score of Cresco Labs?

The AlleAktien quality score for Cresco Labs is 1/10.

What is the revenue of Cresco Labs 2024?

The expected Cresco Labs revenue is 765.59 M USD.

How high is the profit of Cresco Labs 2024?

The expected Cresco Labs profit is -52.93 M USD.

What is the business model of Cresco Labs

Cresco Labs Inc is a company operating in the cannabis industry. Its business model is based on the production and marketing of legal marijuana products in the USA. The company is headquartered in Chicago, Illinois and operates multiple licensed marijuana cultivation and processing facilities in several states. Cresco Labs has two main divisions: marijuana cultivation and processing, as well as distribution and retail. It strives to produce high-quality marijuana products that meet the strict requirements of the states where it operates. The company works closely with regulatory authorities to ensure compliance with regulations. Cresco Labs also invests in research and development to ensure the safety and efficacy of its marijuana products. Its distribution and retail department collaborates with licensed retailers to offer high-quality, legal marijuana products to consumers in different states. The products are divided into two main lines: Reserve, for experienced marijuana consumers, and Remedi, specifically designed for medical purposes. The company also offers brand licenses to other cannabis companies, allowing them to distribute Cresco Labs' products under their own brand names. Overall, Cresco Labs' business model is focused on the production and marketing of high-quality, legal marijuana products in the USA through cultivation, processing, distribution, and retail operations.

What is the Cresco Labs dividend?

Cresco Labs pays a dividend of 0 USD distributed over payouts per year.

How often does Cresco Labs pay dividends?

The dividend cannot currently be calculated for Cresco Labs or the company does not pay out a dividend.

What is the Cresco Labs ISIN?

The ISIN of Cresco Labs is CA22587M1068.

What is the Cresco Labs WKN?

The WKN of Cresco Labs is A2PAHM.

What is the Cresco Labs ticker?

The ticker of Cresco Labs is CL.CN.

How much dividend does Cresco Labs pay?

Over the past 12 months, Cresco Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cresco Labs is expected to pay a dividend of 0 USD.

What is the dividend yield of Cresco Labs?

The current dividend yield of Cresco Labs is .

When does Cresco Labs pay dividends?

Cresco Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cresco Labs?

Cresco Labs paid dividends every year for the past 0 years.

What is the dividend of Cresco Labs?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cresco Labs located?

Cresco Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cresco Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cresco Labs from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Cresco Labs pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Cresco Labs in the year 2023?

In the year 2023, Cresco Labs distributed 0 USD as dividends.

In which currency does Cresco Labs pay out the dividend?

The dividends of Cresco Labs are distributed in USD.

All fundamentals about Cresco Labs

Our stock analysis for Cresco Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cresco Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.